ICR Documents

Supporting Statement A Document Date Uploaded Clean Final NDE ICR SS FINAL.docx 08/03/2023 Supporting Statement B Document Date Uploaded Supplementary Documents Title Document Document Type Date Uploaded Crosswalk 60 to 30 Day Data Elements Cross Walk_508 FINAL.pdf Supplementary Document 06/29/2023 60-day Response to comment document Final clean 60 Day Data Elements Comment Summary Responses.docx Supplementary Document 06/29/2023 Crosswalk - 30day NDE ICR 30 day to final Crosswalk FINAL.docx Supplementary Document 08/03/2023 30-day Response to comment document Clean 30 Day Data Elements Comment Summary Responses FINAL.docx Supplementary Document 08/03/2023 Public Comments Author Name Comment Document Author Affiliation Sponsoring Org. Type Category Date of Comment Date Comment Received Lore , Abigail Abigail Lore (PhRMA 30-day comments - Appendix A).pdf PhRMA Email Simple 04/13/2023 04/13/2023 Nordisk, Novo PC_202306-0938-013_073123_062222_1.pdf NNI - Comment Letter on Revised ICR for Manufacturer Data FINAL 07.31.23.pdf Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Flood, Thad 2023.07.31 AZ-Alexion-Data-Elements-ICR FINAL.pdf PC_202306-0938-013_073123_011901_1.pdf AstraZeneca Pharmaceuticals LP Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Kuntz, Crystal PC_202306-0938-013_073123_114429_1.pdf BIO Negotiation Data Elements 30 Day Comments FINAL 7.31.23.pdf BIO Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Tucker, Caroline BMS ICR Comments_Negotiation Data Elements 07312023.pdf Bristol Myers Squibb (BMS) Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Penn, Michael Final BI Comments to OMB on Revised Medicare Data Elements ICR 07.31.23.pdf PC_202306-0938-013_073123_044956_1.pdf Head of Policy Boehringer Ingelheim Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 O'Connell, Kendalle MassBio Data Elements ICR Comment Letter 7.31.23.pdf PC_202306-0938-013_073123_102554_1.pdf MassBio n/a Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Lore, Abigail Abigail Lore (PhRMA 30-day comments submitted 7-31-23).pdf PhRMA Email Simple 07/31/2023 07/31/2023 Noda, Andrea Arnold Ventures IRA Data Elements Comment Letter_FINAL.pdf Arnold Ventures Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Hancock, Rebecca PC_202306-0938-013_073123_041530_1.pdf JJ Comments - Updated ICR Negotiation Elements 7-31-23.pdf Johnson & Johnson Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Lore, Abigail Abigail Lore (PhRMA 30-day comments - Appendix B).pdf PhRMA Email Simple 05/22/2023 05/22/2023 Lore, Abigail Abigail Lore (PhRMA 30-day comments Cover Sheet).pdf PhRMA Email Simple 07/31/2023 07/31/2023 Santana, Estevan PC_202306-0938-013_073123_031538_1.pdf GNE Final ICR Comment Letter (7-31-23).pdf Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Dhillon, Harmeet PC_202306-0938-013_073123_013907_1.pdf GSK Comment Letter on IRA ICR Negotiation Data Elements - FINAL.pdf Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Garrison, Louis Garrison-Towse MDPNP ICR Comment Letter July 31, 2023.pdf PC_202306-0938-013_073123_054605_1.pdf The CHOICE Institute University of Washington Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Anonymous 60-day comments.pdf Email Multiple 06/29/2023 06/29/2023 Nordyke, Robert FINAL_NPC Comments on Negotiation Data Elements_Second ICR Response_7.31.2023.pdf National Pharmaceutical Council National Pharmaceutical Council Other -- Reginfo.gov Simple 07/31/2023 07/31/2023 Hilligoss, Diane PC_202306-0938-013_073123_081717_1.pdf Lilly Comments - June 30 IRA ICR.pdf Other -- Reginfo.gov Simple 07/31/2023 07/31/2023